Last 7 days
4.3%
Last 30 days
2.7%
Last 90 days
-4.5%
Trailing 12 Months
0.4%
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
PG | 349.4B | 80.3B | 7.19% | -2.65% | 24.47 | 4.35 | 2.47% | -1.59% |
CL | 62.8B | 18.0B | 2.66% | 0.39% | 35.21 | 3.5 | 3.13% | -17.59% |
KMB | 44.9B | 20.2B | 6.37% | 8.36% | 23.21 | 2.23 | 3.78% | 6.62% |
CLX | 19.1B | 7.1B | -0.64% | 13.42% | 43.84 | 2.7 | -0.21% | 76.11% |
CHD | 18.6B | 5.4B | 3.65% | -11.68% | 25.18 | 3.49 | 3.57% | -49.98% |
MID-CAP | ||||||||
REYN | 5.7B | 3.8B | -0.98% | -3.65% | 22.12 | 1.49 | 7.34% | -20.37% |
ELF | 4.2B | 496.6M | 5.58% | 205.77% | 89.58 | 8.45 | 30.80% | 132.00% |
SPB | 2.6B | 3.1B | 0.27% | -27.87% | 61.77 | 0.85 | 2.30% | -66.19% |
ENR | 2.4B | 3.0B | -5.77% | 14.62% | -10.05 | 0.82 | -1.67% | -257.67% |
WDFC | 2.4B | 509.0M | 1.11% | -3.82% | 37.96 | 4.68 | 2.14% | -3.67% |
CENT | 2.1B | 3.3B | -0.32% | -10.09% | 15.73 | 0.64 | -2.01% | -13.17% |
SMALL-CAP | ||||||||
REV | 214.9M | - | -40.09% | -62.17% | -0.3 | 0.1 | - | -56.86% |
NATR | 196.1M | 437.1M | -5.63% | -39.07% | 14.91 | 0.45 | 2.15% | -41.44% |
OBCI | 123.9M | 63.4M | 1.09% | 20.23% | 25.41 | 1.95 | 4.21% | -51.45% |
UG | 43.0M | 13.6M | -20.61% | -56.29% | 14.3 | 3.16 | 7.56% | -27.60% |
Income Statement (Last 12 Months) | (In Millions) | |||||
---|---|---|---|---|---|---|
Description | (%) Q/Q | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 |
Revenue | 1.3% | 17,967 | 17,741 | 17,700 | 17,476 | 17,421 |
Cost Of Revenue | 2.8% | 7,719 | 7,508 | 7,392 | 7,166 | 7,046 |
Gross Profit | 0.1% | 10,248 | 10,233 | 10,308 | 10,310 | 10,375 |
S&GA Expenses | 0.5% | 6,565 | 6,530 | 6,532 | 6,443 | 6,407 |
R&D Expenses | 4.2% | 320 | 307 | - | - | - |
EBITDA | 0.2% | 3,377 | 3,371 | 3,676 | 3,837 | - |
EBITDA Margin | -1.3% | 0.19* | 0.19* | 0.21* | 0.22* | - |
Earnings Before Taxes | -6.7% | 2,660 | 2,852 | 2,813 | 2,925 | 3,087 |
EBT Margin | -7.9% | 0.15* | 0.16* | 0.16* | 0.17* | - |
Interest Expenses | 43.3% | 172 | 120 | - | - | - |
Net Income | -7.4% | 1,785 | 1,928 | 1,944 | 2,044 | 2,166 |
Net Income Margin | -8.6% | 0.10* | 0.11* | 0.11* | 0.12* | - |
Free Cahsflow | -14.5% | 2,556 | 2,989 | 3,014 | 2,546 | - |
Balance Sheet | (In Millions) | |||||
---|---|---|---|---|---|---|
Description | (%) Q/Q | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 |
Assets | -3.4% | 15,731 | 16,288 | 15,711 | 15,723 | 15,040 |
Current Assets | -3.1% | 5,113 | 5,278 | 5,160 | 4,989 | 4,397 |
Cash Equivalents | -17.4% | 775 | 938 | 858 | 877 | 832 |
Inventory | 0.0% | 2,074 | 2,073 | 2,012 | 1,924 | 1,692 |
Net PPE | 4.5% | 4,307 | 4,123 | 3,765 | 3,752 | 3,730 |
Goodwill | 701.9% | 3,352 | 418 | 3,238 | 3,292 | 3,284 |
Liabilities | -2.0% | 14,925 | 15,235 | 15,153 | 14,995 | 14,069 |
Current Liabilities | -10.9% | 4,004 | 4,492 | 4,395 | 4,566 | 4,051 |
LT Debt, Current | 7.7% | 14.00 | 13.00 | 13.00 | 12.00 | 12.00 |
LT Debt, Non Current | 6.4% | 8,741 | 8,219 | 7,957 | 7,588 | 7,194 |
Shareholder's Equity | -35.5% | 401 | 622 | 168 | 321 | 609 |
Retained Earnings | 0.0% | 24,573 | 24,566 | 24,342 | 24,149 | 24,350 |
Additional Paid-In Capital | 0.8% | 3,546 | 3,518 | 3,402 | 3,355 | 3,269 |
Accumulated Depreciation | -1.0% | 5,195 | 5,249 | 5,291 | 5,169 | - |
Shares Outstanding | 0.1% | 835 | 834 | 838 | - | - |
Minority Interest | -6.0% | 405 | 431 | 390 | 407 | 362 |
Cashflow (Last 12 Months) | (In Millions) | |||||
---|---|---|---|---|---|---|
Description | (%) Q/Q | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 |
Cashflow From Operations | -14.5% | 2,556 | 2,989 | 3,014 | 3,113 | 3,325 |
Share Based Compensation | -6.0% | 125 | 133 | 122 | 126 | 135 |
Cashflow From Investing | -2.8% | -1,601 | -1,558 | -785 | -591 | -592 |
Cashflow From Financing | 31.6% | -952 | -1,392 | -2,275 | -2,644 | -2,774 |
Buy Backs | 4.6% | 1,308 | 1,251 | 1,398 | 1,358 | 1,320 |
4.6%
0%
0%
Y-axis is the maximum loss one would have experienced if Colgate-Palmolive was unfortunately bought at previous high price.
4.8%
3.2%
3.3%
6.4%
FIve years rolling returns for Colgate-Palmolive.
Datesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
2023-03-28 | Acrisure Capital Management, LLC | new | - | 1,176,180 | 1,176,180 | 1.30% |
2023-03-27 | Neo Ivy Capital Management | new | - | 353,000 | 353,000 | 0.24% |
2023-03-23 | ETF MANAGERS GROUP, LLC | new | - | 449,497 | 449,497 | 0.02% |
2023-03-23 | MetLife Investment Management, LLC | reduced | -1.72 | 1,742,350 | 18,772,400 | 0.15% |
2023-03-17 | American Portfolios Advisors | added | 0.48 | -239,361 | 1,768,010 | 0.07% |
2023-03-15 | B. Riley Wealth Advisors, Inc. | reduced | -1.16 | 133,411 | 1,375,410 | 0.04% |
2023-03-13 | Claro Advisors LLC | reduced | -1.49 | -41,459 | 1,279,540 | 0.42% |
2023-03-10 | VICTORY CAPITAL MANAGEMENT INC | added | 2.07 | 15,926,100 | 125,909,000 | 0.14% |
2023-03-10 | MATHER GROUP, LLC. | added | 2.81 | 1,642,480 | 12,374,500 | 0.24% |
2023-03-08 | Capital Asset Advisory Services LLC | added | 46.67 | 345,790 | 880,790 | 0.07% |
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Feb 09, 2023 | vanguard group inc | 9.62% | 80,375,011 | SC 13G/A | |
Feb 06, 2023 | state street corp | 5.97% | 49,899,351 | SC 13G/A | |
Feb 03, 2023 | blackrock inc. | 8.1% | 68,041,416 | SC 13G/A | |
Feb 14, 2022 | state street corp | 5.89% | 49,608,335 | SC 13G/A | |
Feb 09, 2022 | vanguard group inc | 9.11% | 76,746,614 | SC 13G/A | |
Feb 01, 2022 | blackrock inc. | 7.7% | 65,218,485 | SC 13G/A | |
Feb 12, 2021 | state street corp | 5.92% | 50,722,444 | SC 13G | |
Feb 10, 2021 | vanguard group inc | 8.83% | 75,657,186 | SC 13G/A | |
Jan 29, 2021 | blackrock inc. | 6.8% | 58,107,209 | SC 13G/A | |
Feb 14, 2020 | state street corp | 6.57% | 56,280,269 | SC 13G |
Fair Value | Very Pessimistic | Pessimistic | Base Case | Optimistic | Very Optimistic |
---|---|---|---|---|---|
Very Low Inflation | 26.40 -64.92% | 35.20 -53.22% | 40.13 -46.67% | 60.83 -19.16% | 76.79 2.05% |
Current Inflation | 23.55 -68.70% | 27.24 -63.80% | 38.60 -48.70% | 54.84 -27.12% | 66.42 -11.73% |
Very High Inflation | 22.24 -70.45% | 27.17 -63.89% | 30.05 -60.07% | 43.43 -42.29% | 53.79 -28.52% |
Date Filed | Form Type | Document | |
---|---|---|---|
Mar 29, 2023 | ARS | ARS | |
Mar 29, 2023 | DEF 14A | DEF 14A | |
Mar 29, 2023 | DEFA14A | DEFA14A | |
Mar 15, 2023 | 4 | Insider Trading | |
Mar 01, 2023 | 4 | Insider Trading | |
Mar 01, 2023 | 4 | Insider Trading | |
Mar 01, 2023 | 424B2 | Prospectus Filed | |
Mar 01, 2023 | 8-K | Current Report | |
Feb 27, 2023 | 424B2 | Prospectus Filed | |
Feb 27, 2023 | FWP | Prospectus Filed |
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
2023-03-13 | Kooyman John W | sold | -146,209 | 71.6709 | -2,040 | chief of staff |
2023-02-27 | POLK MICHAEL B | sold | -408,494 | 73.4834 | -5,559 | - |
2023-02-27 | POLK MICHAEL B | acquired | 408,620 | 71.65 | 5,703 | - |
2023-02-27 | CAHILL JOHN T | sold | -421,075 | 73.8339 | -5,703 | - |
2023-02-27 | CAHILL JOHN T | acquired | 408,620 | 71.65 | 5,703 | - |
2023-02-21 | HARRIS C MARTIN | acquired | 408,620 | 71.65 | 5,703 | - |
2023-02-21 | HARRIS C MARTIN | sold | -423,447 | 74.2498 | -5,703 | - |
2023-02-17 | Massey Sally | sold | -73,904 | 73.2456 | -1,009 | chief human resources officer |
2023-02-17 | Kooyman John W | sold | -111,050 | 73.3004 | -1,515 | chief of staff |
2023-02-17 | Daniels Jennifer | sold | -360,832 | 73.31 | -4,922 | clo and secretary |
Consolidated Statements of Income - USD ($) $ in Millions | 12 Months Ended | ||
---|---|---|---|
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Income Statement [Abstract] | |||
Net sales | $ 17,967 | $ 17,421 | $ 16,471 |
Cost of sales | 7,719 | 7,046 | 6,454 |
Gross profit | 10,248 | 10,375 | 10,017 |
Selling, general and administrative expenses | 6,565 | 6,407 | 6,019 |
Other (income) expense, net | 69 | 65 | 113 |
Goodwill and intangible assets impairment charges | 721 | 571 | 0 |
Operating profit | 2,893 | 3,332 | 3,885 |
Non-service related postretirement costs | 80 | 70 | 74 |
Interest (income) expense, net | 153 | 175 | 164 |
Income before income taxes | 2,660 | 3,087 | 3,647 |
Provision for income taxes | 693 | 749 | 787 |
Net income including noncontrolling interests | 1,967 | 2,338 | 2,860 |
Less: Net income attributable to noncontrolling interests | 182 | 172 | 165 |
Net income attributable to Colgate-Palmolive Company | $ 1,785 | $ 2,166 | $ 2,695 |
Earnings per common share, basic (in dollars per share) | $ 2.13 | $ 2.56 | $ 3.15 |
Earnings per common share, diluted (in dollars per share) | $ 2.13 | $ 2.55 | $ 3.14 |
Consolidated Balance Sheets - USD ($) $ in Millions | Dec. 31, 2022 | Dec. 31, 2021 |
---|---|---|
Current Assets | ||
Cash and cash equivalents | $ 775 | $ 832 |
Receivables (net of allowances of $70 and $78, respectively) | 1,504 | 1,297 |
Inventories | 2,074 | 1,692 |
Other current assets | 760 | 576 |
Total current assets | 5,113 | 4,397 |
Property, plant and equipment, net | 4,307 | 3,730 |
Goodwill | 3,352 | 3,284 |
Other intangible assets, net | 1,920 | 2,462 |
Deferred income taxes | 135 | 193 |
Other assets | 904 | 974 |
Total assets | 15,731 | 15,040 |
Current Liabilities | ||
Notes and loans payable | 11 | 39 |
Current portion of long-term debt | 14 | 12 |
Accounts payable | 1,551 | 1,479 |
Accrued income taxes | 317 | 436 |
Other accruals | 2,111 | 2,085 |
Total current liabilities | 4,004 | 4,051 |
Long-term debt | 8,741 | 7,194 |
Deferred income taxes | 383 | 395 |
Other liabilities | 1,797 | 2,429 |
Total liabilities | 14,925 | 14,069 |
Commitments and contingent liabilities | 0 | 0 |
Shareholders’ Equity | ||
Common stock, $1 par value (2,000,000,000 shares authorized, 1,465,706,360 shares issued) | 1,466 | 1,466 |
Additional paid-in capital | 3,546 | 3,269 |
Retained earnings | 24,573 | 24,350 |
Accumulated other comprehensive income (loss) | (4,055) | (4,386) |
Unearned compensation | (1) | (1) |
Treasury stock, at cost | (25,128) | (24,089) |
Total Colgate-Palmolive Company shareholders’ equity | 401 | 609 |
Noncontrolling interests | 405 | 362 |
Total equity | 806 | 971 |
Total liabilities and equity | $ 15,731 | $ 15,040 |